Fumihiko “Fumi” Urano, MD, PhD, FACMG, is a Physician and Medical Researcher specializing in Wolfram syndrome, characterized by juvenile-onset diabetes, vision loss, and brain system disruption. Dr. Urano is a Professor of Medicine and Pathology & Immunology, an attending physician, and currently holds Samuel E. Schechter Endowed Professorship in Medicine at Washington University School of Medicine. Dr. Urano is a driving force in the study of Wolfram syndrome and Wolfram-spectrum disorders. As the Director of the Wolfram Syndrome International Registry and Clinical Study and WFS1 Clinic at Washington University Medical Center (Wolfram Syndrome International Registry & Clinical Study), Dr. Urano has been leading the clinical, translational, and interventional studies of Wolfram syndrome and Wolfram-spectrum disorder. Dr. Urano’s collaboration with colleagues at the medical center and around the world has allowed him to develop cutting-edge treatments for this disease, including gene therapy and regenerative therapy. Dr. Urano is a scientific co-founder and head of the scientific advisory board for Opris Biotechnologies.
